Martin Huber

2023 - Mersana Therapeutics

In 2023, Martin Huber earned a total compensation of $2.6M as President and Chief Executive Officer at Mersana Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$110,466
Option Awards$1,133,300
Salary$194,311
Stock Awards$880,440
Other$282,733
Total$2,601,249

Huber received $1.1M in option awards, accounting for 44% of the total pay in 2023.

Huber also received $110.5K in non-equity incentive plan, $194.3K in salary, $880.4K in stock awards and $282.7K in other compensation.

Rankings

In 2023, Martin Huber's compensation ranked 375th out of 2,978 executives tracked by ExecPay. In other words, Huber earned more than 87.4% of executives.

ClassificationRankingPercentile
All
375
out of 2,978
87th
Division
Manufacturing
213
out of 1,637
87th
Major group
Chemicals And Allied Products
148
out of 906
84th
Industry group
Drugs
145
out of 869
83rd
Industry
Pharmaceutical Preparations
88
out of 627
86th
Source: SEC filing on April 26, 2024.

Huber's colleagues

We found six more compensation records of executives who worked with Martin Huber at Mersana Therapeutics in 2023.

2023

Anna Protopapas

Mersana Therapeutics

Chief Executive Officer

2023

Arvin Yang

Mersana Therapeutics

Chief Medical Officer

2023

Brian DeSchuytner

Mersana Therapeutics

Chief Financial Officer

2023

Timothy Lowinger

Mersana Therapeutics

Senior Vice President, Chief Science and Technology Officer

2023

Alejandra Carvajal

Mersana Therapeutics

Chief Legal Officer

2023

Mohan Bala

Mersana Therapeutics

Senior Vice President, Chief Development Officer

News

You may also like